Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody.

    Portalès P, Fabre S, Vincent T, Desmetz C, Réant B, Noël D, Clot J, Jorgensen C, Corbeau P.

    Immunology. 2009 Sep;128(1 Suppl):e738-45. Epub 2009 Mar 26.PMID: 19740335 [PubMed - in process]Related articles

    2.

    CCR5 antagonism in HIV infection: ways, effects, and side effects.

    Corbeau P, Reynes J.

    AIDS. 2009 Sep 24;23(15):1931-43. No abstract available. PMID: 19724192 [PubMed - in process]Related articles

    3.

    CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C.

    Perney P, Turriere C, Portalès P, Rigole H, Psomas C, Blanc F, Clot J, Corbeau P.

    Clin Immunol. 2009 Jul;132(1):55-62. Epub 2009 May 6.PMID: 19423402 [PubMed - indexed for MEDLINE]Related articles

    4.

    Interfering RNA and HIV: reciprocal interferences.

    Corbeau P.

    PLoS Pathog. 2008 Sep 26;4(9):e1000162. Review.PMID: 18818734 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Galphai protein-dependant extracellular signal-regulated kinase-1/2 activation is required for HIV-1 reverse transcription.

    Mettling C, Desmetz C, Fiser AL, Réant B, Corbeau P, Lin YL.

    AIDS. 2008 Aug 20;22(13):1569-76.PMID: 18670215 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effective gene therapy in a mouse model of prion diseases.

    Toupet K, Compan V, Crozet C, Mourton-Gilles C, Mestre-Francés N, Ibos F, Corbeau P, Verdier JM, Perrier V.

    PLoS One. 2008 Jul 23;3(7):e2773.PMID: 18648643 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.

    Lin YL, Mettling C, Portalès P, Rouzier R, Clot J, Reynes J, Corbeau P.

    AIDS. 2008 Jan 30;22(3):430-2.PMID: 18195571 [PubMed - indexed for MEDLINE]Related articles

    8.

    Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance.

    Bakkour N, Lin YL, Maire S, Ayadi L, Mahuteau-Betzer F, Nguyen CH, Mettling C, Portales P, Grierson D, Chabot B, Jeanteur P, Branlant C, Corbeau P, Tazi J.

    PLoS Pathog. 2007 Oct 26;3(10):1530-9.PMID: 17967062 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.

    Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, Corbeau P, Sotto A, Lavigne JP.

    Diabetologia. 2008 Feb;51(2):347-52. Epub 2007 Oct 13.PMID: 17934713 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.

    Desmetz C, Lin YL, Mettling C, Portalès P, Noël D, Clot J, Jorgensen C, Corbeau P.

    Clin Immunol. 2007 May;123(2):148-54. Epub 2007 Mar 23.PMID: 17363330 [PubMed - indexed for MEDLINE]Related articles

    11.

    Suppression of microRNA-silencing pathway by HIV-1 during virus replication.

    Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M.

    Science. 2007 Mar 16;315(5818):1579-82. Epub 2007 Feb 22.PMID: 17322031 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency.

    du Chéné I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia C, Mettling C, Baillat V, Reynes J, Corbeau P, Bertrand E, Marcello A, Emiliani S, Kiernan R, Benkirane M.

    EMBO J. 2007 Jan 24;26(2):424-35.PMID: 17245432 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.

    Desmetz C, Lin YL, Mettling C, Portalès P, Rabesandratana H, Clot J, Corbeau P.

    Immunology. 2006 Dec;119(4):551-61.PMID: 17177831 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The immunological response to highly active antiretroviral therapy is linked to CD4+ T-cell surface CCR5 density.

    Vincent T, Portalès P, Baillat V, Eden A, Clot J, Reynes J, Corbeau P.

    J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):377-8. No abstract available. PMID: 17079996 [PubMed - indexed for MEDLINE]Related articles

    15.

    The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.

    Lin YL, Mettling C, Portalès P, Réant B, Robert-Hebmann V, Reynes J, Clot J, Corbeau P.

    AIDS. 2006 Jun 26;20(10):1369-77.PMID: 16791011 [PubMed - indexed for MEDLINE]Related articles

    16.

    CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

    Lin YL, Portales P, Segondy M, Baillat V, de Boever CM, Le Moing V, Réant B, Montes B, Clot J, Reynes J, Corbeau P.

    J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6.PMID: 16044003 [PubMed - indexed for MEDLINE]Related articles

    17.

    G-protein signaling triggered by R5 human immunodeficiency virus type 1 increases virus replication efficiency in primary T lymphocytes.

    Lin YL, Mettling C, Portalès P, Réant B, Clot J, Corbeau P.

    J Virol. 2005 Jun;79(12):7938-41.PMID: 15919952 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.

    Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.

    Br J Dermatol. 2005 Apr;152(4):690-6.PMID: 15840100 [PubMed - indexed for MEDLINE]Related articles

    19.

    T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists.

    Vincent T, Portales P, Baillat V, de Boever CM, Le Moing V, Vidal M, Ducos J, Clot J, Reynes J, Corbeau P.

    J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):305-9.PMID: 15735449 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.

    Bachrach E, Dreja H, Lin YL, Mettling C, Pinet V, Corbeau P, Piechaczyk M.

    Virology. 2005 Feb 5;332(1):418-29.PMID: 15661172 [PubMed - indexed for MEDLINE]Related articles

    21.

    Diminished CD4+ T cell surface CCR5 expression in alcoholic patients.

    Perney P, Portalès P, Clot J, Blanc F, Corbeau P.

    Alcohol Alcohol. 2004 Nov-Dec;39(6):484-5. Epub 2004 Oct 21.PMID: 15498817 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

    Crozet C, Lin YL, Mettling C, Mourton-Gilles C, Corbeau P, Lehmann S, Perrier V.

    J Cell Sci. 2004 Nov 1;117(Pt 23):5591-7. Epub 2004 Oct 19.PMID: 15494372 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects.

    Portales P, Guerrier T, Clot J, Corbeau P, Mettling C, Lin YL, Baillat V, de Boever CM, Le Moing V, Tramoni C, Reynes J, Segondy M.

    Clin Nutr. 2004 Oct;23(5):1244-5. No abstract available. PMID: 15380918 [PubMed - indexed for MEDLINE]Related articles

    24.

    Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritis.

    Lin YL, Noël D, Mettling C, Réant B, Clot J, Jorgensen C, Corbeau P.

    Hum Gene Ther. 2004 Jun;15(6):588-96.PMID: 15212717 [PubMed - indexed for MEDLINE]Related articles

    25.

    Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy.

    Reynes J, Baillat V, Portales P, Clot J, Corbeau P.

    JAMA. 2004 Jan 7;291(1):46. No abstract available. PMID: 14709574 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Specific alteration of peripheral cytotoxic cell perforin expression in alcoholic patients: a possible role in alcohol-related diseases.

    Perney P, Portalès P, Corbeau P, Roques V, Blanc F, Clot J.

    Alcohol Clin Exp Res. 2003 Nov;27(11):1825-30.PMID: 14634500 [PubMed - indexed for MEDLINE]Related articles

    27.

    Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection.

    Reynes J, Baillat V, Portales P, Clot J, Corbeau P.

    J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):114-6. No abstract available. PMID: 14501804 [PubMed - indexed for MEDLINE]Related articles

    28.

    Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection.

    Portales P, Reynes J, Rouzier-Panis R, Baillat V, Clot J, Corbeau P.

    AIDS. 2003 Mar 7;17(4):505-11.PMID: 12598770 [PubMed - indexed for MEDLINE]Related articles

    29.

    Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo.

    Portales P, Reynes J, Pinet V, Rouzier-Panis R, Baillat V, Clot J, Corbeau P.

    AIDS. 2003 Mar 7;17(4):495-504.PMID: 12598769 [PubMed - indexed for MEDLINE]Related articles

    30.

    Rare occurrence of CD30+ circulating cells in patients with cutaneous CD30+ anaplastic large cell lymphoma: a study of nine patients.

    Dereure O, Portales P, Balavoine M, Corbeau P, Guillot B, Clot J, Guilhou JJ.

    Br J Dermatol. 2003 Feb;148(2):246-51.PMID: 12588375 [PubMed - indexed for MEDLINE]Related articles

    31.

    Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

    Lin YL, Mettling C, Portales P, Reynes J, Clot J, Corbeau P.

    Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15590-5. Epub 2002 Nov 14.PMID: 12434015 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection.

    Gervaix A, Nicolas J, Portales P, Posfay-Barbe K, Wyler CA, Segondy M, Avinens O, Siegrist CA, Clot J, Eliaou JF, Astruc J, Corbeau P.

    J Infect Dis. 2002 Apr 15;185(8):1055-61. Epub 2002 Apr 1.PMID: 11930315 [PubMed - indexed for MEDLINE]Related articles

    33.

    CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

    Reynes J, Portales P, Segondy M, Baillat V, André P, Avinens O, Picot MC, Clot J, Eliaou JF, Corbeau P.

    AIDS. 2001 Sep 7;15(13):1627-34.PMID: 11546936 [PubMed - indexed for MEDLINE]Related articles

    34.

    Sex differences in HIV-1 viral load due to sex difference in CCR5 expression.

    Portales P, Clot J, Corbeau P.

    Ann Intern Med. 2001 Jan 2;134(1):81-2. No abstract available. PMID: 11187428 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Reply

    Reynes J, Portales P, Clot J, Corbeau P.

    J Infect Dis. 2000 Oct;182(4):1285-6. No abstract available. PMID: 10979937 [PubMed - as supplied by publisher]Related articles

    36.

    CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

    Reynes J, Portales P, Segondy M, Baillat V, André P, Réant B, Avinens O, Couderc G, Benkirane M, Clot J, Eliaou JF, Corbeau P.

    J Infect Dis. 2000 Mar;181(3):927-32.PMID: 10720514 [PubMed - indexed for MEDLINE]Related articles

    37.

    Anti-HIV effects of HIV vectors.

    Corbeau P, Wong-Staal F.

    Virology. 1998 Apr 10;243(2):268-74.PMID: 9568026 [PubMed - indexed for MEDLINE]Related articles

    38.

    Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system.

    Corbeau P, Kraus G, Wong-Staal F.

    Gene Ther. 1998 Jan;5(1):99-104.PMID: 9536270 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line.

    Corbeau P, Kraus G, Wong-Staal F.

    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14070-5.PMID: 8943062 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Development of HIV vectors for anti-HIV gene therapy.

    Poeschla E, Corbeau P, Wong-Staal F.

    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11395-9. Review.PMID: 8876146 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Jacalin, a lectin interacting with O-linked sugars and mediating protection of CD4+ cells against HIV-1, binds to the external envelope glycoprotein gp120.

    Corbeau P, Pasquali JL, Devaux C.

    Immunol Lett. 1995 Jul-Aug;47(1-2):141-3. No abstract available. PMID: 8537092 [PubMed - indexed for MEDLINE]Related articles

    42.

    Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.

    Corbeau P, Haran M, Binz H, Devaux C.

    Mol Immunol. 1994 Jun;31(8):569-75.PMID: 8196669 [PubMed - indexed for MEDLINE]Related articles

    43.

    An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells.

    Benkirane M, Corbeau P, Housset V, Devaux C.

    EMBO J. 1993 Dec 15;12(13):4909-21.PMID: 7505220 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosis.

    Lallement JC, Vendrell JP, Corbeau P, Ducos J, Segondy M, Escande A, Robert-Hebmann V, Jean F, Reynes J, Serre A, et al.

    J Clin Microbiol. 1993 Jul;31(7):1903-7.PMID: 7688755 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.

    Favero J, Corbeau P, Nicolas M, Benkirane M, Travé G, Dixon JF, Aucouturier P, Rasheed S, Parker JW, Liautard JP, et al.

    Eur J Immunol. 1993 Jan;23(1):179-85.PMID: 8419169 [PubMed - indexed for MEDLINE]Related articles

    46.

    Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.

    Corbeau P, Benkirane M, Weil R, David C, Emiliani S, Olive D, Mawas C, Serre A, Devaux C.

    J Immunol. 1993 Jan 1;150(1):290-301.PMID: 7678031 [PubMed - indexed for MEDLINE]Related articles

    47.

    Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease.

    Poncelet P, Poinas G, Corbeau P, Devaux C, Tubiana N, Muloko N, Tamalet C, Chermann JC, Kourilsky F, Sampol J.

    Res Immunol. 1991 May;142(4):291-8.PMID: 1718020 [PubMed - indexed for MEDLINE]Related articles

    48.

    Anti-HLA antigen class I heavy chain monoclonal antibodies inhibit human immunodeficiency virus production by peripheral blood mononuclear cells.

    Corbeau P, Olive D, Devaux C.

    Eur J Immunol. 1991 Apr;21(4):865-71.PMID: 2019288 [PubMed - indexed for MEDLINE]Related articles

    49.

    Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly.

    Pautrat G, Suzan M, Salaun D, Corbeau P, Allasia C, Morel G, Filippi P.

    Virology. 1990 Dec;179(2):749-58.PMID: 1700541 [PubMed - indexed for MEDLINE]Related articles

    50.

    Anti-beta 2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells.

    Devaux C, Boucraut J, Poirier G, Corbeau P, Rey F, Benkirane M, Perarnau B, Kourilsky F, Chermann JC.

    Res Immunol. 1990 May-Jun;141(4-5):357-72.PMID: 2267410 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...